The Australasian journal of dermatology
Sustained Remission of Refractory Folliculitis Decalvans With Secukinumab After Loss of Response to Adalimumab.
Silvia Vázquez-Gómez, Alba Díaz-Fernández
Published: 202510.1111/ajd.14627
No abstract available for this study.